Company Description
ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States.
The company operates in two segments, ARCpoint Franchise and AFG Services. It offers clinical healthcare; viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, thyroid, diabetes, and hormone testing and screening; nutritional testing comprising food allergy/sensitivity and vitamin/nutrient deficiency testing; and specialty health solutions such as TB and titer, pregnancy, respiratory, and blood type testing services, as well as vaccine, vitamin, and supplements injections.
The company also provides drug, alcohol, EtG, marijuana, PEth, unknown substances, and on-site mobile testing; paternity and DNA services; STD; and dry eyes testing services.
In addition, it offers employer solutions consisting of DOT solutions, background screening, HR employment solutions, and corporate wellness programs.
Further, the company provides marketing, technology, and training services. It provides services to individuals, companies, and legal and healthcare professionals.
The company was formerly known as RSI International Systems Inc. ARCpoint Inc. was founded in 1998 and is headquartered in Greenville, South Carolina.
| Country | Canada |
| Founded | 1998 |
| IPO Date | Feb 4, 2005 |
| Industry | Specialty Business Services |
| Sector | Industrials |
| Employees | 1,900 |
| CEO | John Constantine |
Contact Details
Address: 101 North Main Street Greenville, California 29601 United States | |
| Phone | 864 436 0018 |
| Website | arcpointlabs.com |
Stock Details
| Ticker Symbol | ARC |
| Exchange | NYSE |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001305168 |
| CUSIP Number | 00191G103 |
| ISIN Number | US00191G1031 |
| Employer ID | 20-1700361 |
| SIC Code | 7370 |
Key Executives
| Name | Position |
|---|---|
| Kumarakulasingam Suriyakumar | Chairman of the Board and Chief Executive Officer |
| Jorge Avalos | Chief Financial Officer |
| Rahul K. Roy | Chief Technology Officer |
| Tracey M. Luttrell Esq. | Corporate Counsel, Corporate Secretary and Director |
| Dilantha Wijesuriya | President and Chief Operating Officer |
| Ken Gini | Senior Vice President of Corporate Administration, Operations and Procurement |
| David Stickney | Vice President of Corporate Communications and Investor Relations |
| J. Theodore Carlson | Senior Vice President of Mergers and Acquisitions |
| Ted Buscaglia | Executive Vice President of Global Services |
| John J. Zulli III | Executive Vice President of Operations - North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 22, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Nov 22, 2024 | 25-NSE | Filing |
| Nov 22, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Nov 22, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Nov 22, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Nov 22, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Nov 22, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Nov 22, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Nov 22, 2024 | POS AM | Post-Effective amendments for registration statement |
| Nov 22, 2024 | SC 13E3/A | [Amend] Going private transaction by certain issuers |